Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Expert Review of Anticancer Therapy|December 10, 2013
Temsirolimus for advanced renal cell carcinomaLothar Bergmann, Luise Maute, Michael GuschmannDeutsche Medizinische Wochenschrift (1946)|April 1, 2016
[Systemic therapy of metastatic renal cell carcinoma]Luise Maute, Lothar BergmannTumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 16, 2011
The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell linesWolfgang Glienke, Luise Maute, Johannes Wicht, et al.European Journal of Cancer (Oxford, England : 1990)|February 7, 2009
Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cellsWolfgang Glienke, Luise Maute, Johannes Wicht, et al.Cancer Chemotherapy and Pharmacology|September 27, 2008
Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in GermanyHolger Gerullis, Lothar Bergmann, Luise Maute, et al.Medical Oncology (Northwood, London, England)|April 29, 2009
Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinomaHolger Gerullis, Lothar Bergmann, Luise Maute, et al.Journal of Cancer Research and Clinical Oncology|February 22, 2014
Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysisLuise Maute, Viktor Grünwald, Steffen Weikert, et al.Oncology Research and Treatment|June 17, 2020
A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer SocietyLothar Bergmann, Viktor Grünwald, Luise Maute, et al.Onkologie|February 19, 2010
[Sunitinib--from paradigm shift to standard treatment of metastatic renal cell carcinoma]Lothar BergmannOnkologie|February 19, 2010
[Outlook: Future therapy of renal cell carcinoma]Lothar Bergmann, Kurt MillerPageof 6